HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DoJ Prosecutions: USPlabs Guilty, DMBA Firm Indicted From FDA Investigations

Executive Summary

USPlabs executives, others plead guilty to felony charges stemming from marketing unsafe products labeled as supplements but containing DMAA and linked to hepatitis. Blackstone Labs and other firms indicted on felony charges following FDA investigation for marketing DMBA-containing products. "It's all very welcome news, but I'm not sure this is going to change the overall environment," says Pieter Cohen, a physician who advocates for tighter regulation of supplement manufacturing and marketing.

Advertisement

Related Content

Modernizing FDA's Supplement Industry Regulation Mapped Out In Five-Point Plan
S.K. Labs VP Imprisoned Before Trial On Charges Linked To USPlabs
FDA Chases Another Synthetic Stimulant Off Supplement Ingredient Menu
In Brief: CDC calls for safer cough/cold delivery, USPlabs toes the line, Neptune disputes fine, and more
DMAA Product OxyElite Pro Named Potential Link In Acute Hepatitis Cases
USPlabs Crafts DMAA Defense As Shield Against Further Damage

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS148626

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel